1. Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis
   T. A. Bogush et al, 2018, Doklady Biochemistry and Biophysics CrossRef
2. High Ki-67 expression is significantly associated with poor prognosis of ovarian cancer patients: evidence from a meta-analysis
   Dongmei Qiu et al, 2019, Archives of Gynecology and Obstetrics CrossRef
3. Estimating pathological prognostic factors in epithelial ovarian cancers using apparent diffusion coefficients of functional tumor volume
   Cheng Zhang et al, 2024, European Journal of Radiology CrossRef
4. DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma
   Yi Cao et al, 2017, Oncology Letters CrossRef
5. Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis
   Hui Luo et al, 2017, Oncotarget CrossRef
6. Ki-67/MIB-1 as a Prognostic Marker in Cervical Cancer - a Systematic Review with Meta-Analysis
   Reza Piri et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
7. Validation of a two-tier grading system in an unselected, consecutive cohort of serous ovarian cancer patients
   Marco Johannes Battista et al, 2016, Archives of Gynecology and Obstetrics CrossRef
8. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
   I.-M. Launonen et al, 2022, Nature Communications CrossRef
9. Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis
   Zhaojun Shen et al, 2017, Oncotarget CrossRef
10. Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients
    Marco Johannes Battista et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
11. Does Ki-67 Have a Role in the Diagnosis of Placental Molar Disease?
    Rofieda Alwaqfi et al, 2020, International Journal of Gynecological Pathology CrossRef
12. The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?
    Tatiana A. Bogush et al, 2022, Irish Journal of Medical Science (1971 -) CrossRef
13. c-met is overexpressed in type I ovarian cancer: Results of an investigative analysis in a cohort of consecutive ovarian cancer patients
    Marco Johannes Battista et al, 2016, Oncology Letters CrossRef
14. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway
    Haiyuan Liu et al, 2016, Tumor Biology CrossRef
15. Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study
    Marco Johannes Battista et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
16. Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis
    Chun Wai Ng et al, 2022, Journal of Ovarian Research CrossRef
17. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
    Seema C. Parte et al, 2018, Journal of Ovarian Research CrossRef